Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TruScreen Group Ltd. ( (AU:TRU) ) has issued an announcement.
TruScreen Group Limited reported a decrease in revenue and net profit for the fiscal year ending March 2025, largely due to delays in program roll-outs and product registrations in key markets such as Vietnam and Indonesia. Despite these setbacks, the company is optimistic about future growth, with strategic expansions in China and India, and a new screening program in Vietnam. The company expects sales to rebound in FY2026, driven by completed product registrations and new distribution agreements.
More about TruScreen Group Ltd.
TruScreen Group Limited is a cervical cancer technology company that focuses on developing and distributing screening devices. The company is primarily active in emerging markets, with significant operations in China, India, Vietnam, and Indonesia.
Average Trading Volume: 173,514
Technical Sentiment Signal: Buy
Current Market Cap: A$15.34M
For an in-depth examination of TRU stock, go to TipRanks’ Stock Analysis page.